Following the publication of volume 17, issue 6 of Pharmacogenomics, it has been brought to our attention that the article order was incorrect.
The incorrect page numbers were previously:
A Calcagno, G Di Perri & S Bonora. What do we know about tailoring treatment with tenofovir? Pharmacogenomics 17(6), 531–534 (2016).
SB Haga & J Moaddeb. Proposal for a pharmacogenetics certificate program for pharmacists. Pharmacogenomics 17(6), 535–539 (2016).
T Bellon, E Ramirez, AM Borobia et al. The HLA-B*15:02 allele in a Spanish Romani patient with carbamazepine-induced Stevens–Johnson syndrome. Pharmacogenomics 17(6), 541–545 (2016).
A Hahn, T Fukuda, D Hahn et al. Pharmacokinetics and pharmacogenomics of β-lactam-induced neutropenia. Pharmacogenomics 17(6), 547–559 (2016).
J Cusato, S Allegra, S De Francia et al. Role of pharmacogenetics on deferasirox AUC and efficacy. Pharmacogenomics 17(6), 561–572 (2016).
MACSM Borba, RP Melo-Neto, GM Leitão et al. Evaluating the impact of missenses mutations in CYP2D6*7 and CYP2D6*14A: does it compromise tamoxifen metabolism? Pharmacogenomics 17(6), 573–582 (2016).
M Leusink, AH Maitland-van der Zee, B Ding et al. A genetic risk score is associated with statin-induced low-density lipoprotein cholesterol lowering. Pharmacogenomics 17(6), 583–591 (2016).
D Riddle, M Gregoski, K Baker et al. Impressions of pharmacogenomic testing among Certified Registered Nurse Anesthetists: a mixed-method study. Pharmacogenomics 17(6), 593–602 (2016).
JK Mukonzo, RK Bisaso, J Ogwal-Okeng et al. CYP2B6 genotype-based efavirenz dose recommendations during rifampicin-based antituberculosis cotreatment for a sub-Saharan Africa population. Pharmacogenomics 17(6), 603–613 (2016).
W Brian, LM Tremaine, M Arefayene et al. Assessment of drug-metabolism enzyme and transporter-pharmacogenetics in drug discovery and early development: perspectives of the I-PWG. Pharmacogenomics 17(6), 615–631 (2016).
LM Roy, RM Zur, E Uleryk et al. Pharmacogenetic aspects of the treatment of Type 2 diabetes with the incretin effect enhancers. Pharmacogenomics 17(6), 633–656 (2016).
The page numbers are now corrected to:
A Calcagno, G Di Perri & S Bonora. What do we know about tailoring treatment with tenofovir? Pharmacogenomics 17(6), 531–534 (2016).
SB Haga & J Moaddeb. Proposal for a pharmacogenetics certificate program for pharmacists. Pharmacogenomics 17(6), 535–539 (2016).
T Bellon, E Ramirez, AM Borobia et al. The HLA-B*15:02 allele in a Spanish Romani patient with carbamazepine-induced Stevens–Johnson syndrome. Pharmacogenomics 17(6), 541–545 (2016).
A Hahn, T Fukuda, D Hahn et al. Pharmacokinetics and pharmacogenomics of β-lactam-induced neutropenia. Pharmacogenomics 17(6), 547–559 (2016).
MACSM Borba, RP Melo-Neto, GM Leitão et al. Evaluating the impact of missenses mutations in CYP2D6*7 and CYP2D6*14A: does it compromise tamoxifen metabolism? Pharmacogenomics 17(6), 561–570 (2016).
J Cusato, S Allegra, S De Francia et al . Role of pharmacogenetics on deferasirox AUC and efficacy. Pharmacogenomics 17(6), 571–582(2016).
M Leusink, AH Maitland-van der Zee, B Ding et al. A genetic risk score is associated with statin-induced low-density lipoprotein cholesterol lowering. Pharmacogenomics 17(6), 583–591 (2016).
D Riddle, M Gregoski, K Baker et al. Impressions of pharmacogenomic testing among Certified Registered Nurse Anesthetists: a mixed-method study. Pharmacogenomics 17(6), 593–602 (2016).
JK Mukonzo, RK Bisaso, J Ogwal-Okeng et al. CYP2B6 genotype-based efavirenz dose recommendations during rifampicin-based antituberculosis cotreatment for a sub-Saharan Africa population. Pharmacogenomics 17(6), 603-613 (2016).
W Brian, LM Tremaine, M Arefayene et al. Assessment of drug-metabolism enzyme and transporter-pharmacogenetics in drug discovery and early development: perspectives of the I-PWG. Pharmacogenomics 17(6), 615–631 (2016).
LM Roy, RM Zur, E Uleryk et al. Pharmacogenetic aspects of the treatment of Type 2 diabetes with the incretin effect enhancers. Pharmacogenomics 17(6), 633–656 (2016).
The Editors of Pharmacogenomics would like to sincerely apologise for any inconvenience this may have cuased our readers.